Singh T J, Wang J Z, Novak M, Kontzekova E, Grundke-Iqbal I, Iqbal K
New York State Institute for Basic Research in Development Disabilities, Staten Island, New York, NY 10314, USA.
FEBS Lett. 1996 Jun 3;387(2-3):145-8. doi: 10.1016/0014-5793(96)00485-1.
PHF-tau, which is phosphorylated at 10 Ser/Thr-Pro and 11 non-Ser/Thr-Pro sites, is unable to promote microtubule assembly. Phosphorylation of the non-Ser/Thr-Pro site, Ser-262, is reported to be primarily responsible for this. The identities of kinase(s) responsible for Ser-262 phosphorylation are still to be clarified. In this study we have used the monoclonal antibody 12E8, which recognizes P-Ser-262 and P-Ser-356 on tau, to survey different kinases for their abilities to phosphorylate Ser-262 on human tau 3L (tau410). In decreasing order of effectiveness we found that Ser-262 and Ser-356 phosphorylation can be catalyzed by CaM kinase II >> C-kinase >> GSK-3 approximately = A-kinase >> CK-1. CaM kinase II and C-kinase were shown to phosphorylate both Ser-262 and Ser-356. The binding of tau to taxol-stabilized microtubules was decreased by 35 and 42% after phosphorylation by CaM kinase II and C-kinase, respectively. Of the fraction of tau that bound to microtubules, about 50% was phosphorylated at Ser-262 and Ser-356. These results suggest that Ser-262 and Ser-356 are very good substrates for CaM kinase II but their phosphorylations are not sufficient to achieve maximal inhibition of tau binding to microtubules.
在10个丝氨酸/苏氨酸-脯氨酸位点和11个非丝氨酸/苏氨酸-脯氨酸位点发生磷酸化的PHF-tau无法促进微管组装。据报道,非丝氨酸/苏氨酸-脯氨酸位点Ser-262的磷酸化对此起主要作用。负责Ser-262磷酸化的激酶的具体身份仍有待阐明。在本研究中,我们使用了单克隆抗体12E8,它能识别tau上的P-Ser-262和P-Ser-356,来检测不同激酶对人tau 3L(tau410)上Ser-262的磷酸化能力。我们发现,按有效性从高到低排序,Ser-262和Ser-356的磷酸化可由钙调蛋白激酶II >> C激酶 >> GSK-3 大致 = A激酶 >> CK-1催化。钙调蛋白激酶II和C激酶被证明能使Ser-262和Ser-356都发生磷酸化。经钙调蛋白激酶II和C激酶磷酸化后,tau与紫杉醇稳定的微管的结合分别减少了35%和42%。在与微管结合的tau部分中,约50%在Ser-262和Ser-356处发生了磷酸化。这些结果表明,Ser-262和Ser-356是钙调蛋白激酶II的良好底物,但它们的磷酸化不足以完全抑制tau与微管的结合。